CDKN2A and cancer: Adenovirus-mediated delivery of ARF had mostly been used experimentally in vitro, until recent studies showing its potential application using in vivo mouse cancer models (Saadatmandi et al., 2002; Tango et al., 2002; Cerqueira et al., 2020).